Thomasin C, Merkle H P, Gander B
Department of Pharmacy, ETH, Zurich, Switzerland.
J Pharm Sci. 1998 Mar;87(3):269-75. doi: 10.1021/js970048j.
Phase separation (frequently called coacervation) of poly(lactide) (PLA) and poly(lactide-co-glycolide) (PLGA) is a classical method for drug microencapsulation. Here, attempts have been made to describe this process in the light of thermodynamics. Different PLA/PLGAs were dissolved in either dichloromethane or ethyl acetate, phase separated by addition of the coacervating agent silicone oil (PDMS), and hardened in either octamethylcyclotetrasiloxane or hexane. Various stages of phase separation were defined microscopically, and the coacervate and continuous phases characterized with respect to volume, composition, polymer molecular weight, and rheological behavior. The optimal amount of PDMS was inversely proportional to the polymer molecular weight and hydrophilicity, and a coacervate viscosity of above 5-10 Pa s was required for stable coacervate droplets. The composition and, consequently, viscosity of the coacervate and continuous phases depended on the polymer-solvent-PDMS interactions, as analyzed by the parameters chi (Flory), delta (Hildebrand), and delta(int)E (Hô). In general, the lattice model of FIory and Scott describing polymer-polymer incompatibility best explained the results. The interaction parameters and viscosity of the phases were also helpful to explain microsphere characteristics such as residual solvent and particle size. The data suggest that microsphere formation by polyester coacervation is primarily driven by molecular interactions between polymer, solvents, and coacervating agent.
聚乳酸(PLA)和聚乳酸 - 乙醇酸共聚物(PLGA)的相分离(通常称为凝聚)是药物微囊化的经典方法。在此,已尝试从热力学角度描述这一过程。将不同的PLA/PLGA溶解于二氯甲烷或乙酸乙酯中,通过添加凝聚剂硅油(PDMS)进行相分离,并在八甲基环四硅氧烷或己烷中硬化。通过显微镜确定相分离的各个阶段,并对凝聚相和连续相的体积、组成、聚合物分子量和流变行为进行表征。PDMS的最佳用量与聚合物分子量和亲水性成反比,稳定的凝聚液滴需要凝聚相粘度高于5 - 10 Pa·s。凝聚相和连续相的组成以及因此的粘度取决于聚合物 - 溶剂 - PDMS相互作用,通过参数χ(弗洛里)、δ(希尔德布兰德)和δ(int)E(霍)进行分析。一般来说,描述聚合物 - 聚合物不相容性的弗洛里和斯科特晶格模型最能解释结果。相的相互作用参数和粘度也有助于解释微球特性,如残留溶剂和粒径。数据表明,聚酯凝聚法形成微球主要是由聚合物、溶剂和凝聚剂之间分子相互作用驱动的。